CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 4,410 shares (grant or award)
- 4 Grant or award Director acquired 4,410 shares (grant or award)
- 4 Grant or award Director acquired 4,410 shares (grant or award)
- 4 Grant or award Director acquired 4,410 shares (grant or award)
- 4 Grant or award Director acquired 4,410 shares (grant or award)
- 4 Grant or award Director acquired 4,410 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale HEAD OF RARE DISEASE sold 2,000 shares at $61.61 ($123,220)
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 12,855 shares at $61.81 ($794,568)
- 144 Insider Sale of Securities
- 4 Planned sale HEAD OF R&D, COO-NOVITIUM OPS sold 37,145 shares at an average $64.37 ($2,391,121)
- 4 Open-market sale Director sold 2,000 shares at $63.87 ($127,740)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale PRESIDENT & CEO sold 16,669 shares at $66.10 ($1,101,821)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations · Regulation FD disclosure
Page 15 of 90 · 1,784 filings